Treatment outcome, cognitive function, and psychopathology in methamphetamine users compared to other substance users

doi:10.5498/wjp.v12.i7.944

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3530)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-6) series.

Item

Count

PDF

182

WORD

HTML

1274

Figures (1-4)

141

Tables (1-6)

125

Sum=1777

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

198

Download

590

Sum=788

Publishing Process of This Article

Item

Count

Browse

278

Download

687

Sum=965

Jul 19, 2022 (publication date) through Jul 23, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Psychiatry. Jul 19, 2022; 12(7): 944-957
Published online Jul 19, 2022. doi: 10.5498/wjp.v12.i7.944

Table 6 Comparison over time and between groups (ANOVA results)

		MA-group	n	OS-group	n	P
BDI	T0	15.31 (± 11.55)	26	16.36 (± 12.39)	33	P_time^b; P_grou_P_NS; P_timex_grou_P_NS^.
BDI	T1	7.27 (± 7.20)	26	8.97 (± 8.98)	33	P_time^b; P_grou_P_NS; P_timex_grou_P_NS^.
Cognitrone accuracy	T0	43.62 (± 7.84)	26	44.93 (± 9.85)	28	P_time^b; P_grou_P_NS; P_timex_grou_P_NS
Cognitrone accuracy	T1	50.50 (± 8.63)	26	52.54 (± 10.16)	28	P_time^b; P_grou_P_NS; P_timex_grou_P_NS
Cognitrone speed	T0	48.81 (± 7.68)	26	57.18 (± 9.05)	28	P_time^b; P_grou_P^b;P_timex_grou_P_NS^.
Cognitrone speed	T1	54.08 (± 10.04)	26	62.61 (± 10.88)	28	P_time^b; P_grou_P^b;P_timex_grou_P_NS^.
HAMD	T0	6.52 (± 5.36)	25	9.59 (± 9.14)	27	P_time^b; P_grou_P_NS; P_timex_grou_P_NS^.
HAMD	T1	3.60 (± 4.77)	25	5.81 (± 5.98)	27	P_time^b; P_grou_P_NS; P_timex_grou_P_NS^.
IPR	T0	204.43 (± 36.47)	21	201.78 (± 33.84)	27	P_time^a; P_grou_P_NS; P_timex_grou_P_NS^.
IPR	T1	215.48 (± 38.71)	21	217.78 (± 54.15)	27	P_time^a; P_grou_P_NS; P_timex_grou_P_NS^.
MaCS	T0	14.39 (± 9.81)	23	14.59 (± 6.69)	27	P_time^b; P_grou_P_NS; P_timex_grou_P_NS^.
MaCS	T1	8.57 (± 5.71)	23	8.96 (± 8.04)	27	P_time^b; P_grou_P_NS; P_timex_grou_P_NS^.
SCL 90R Depression Score	T0	58.14 (± 9.09)	21	62.70 (± 10.52)	27	P_time^b; P_grou_P_NS; P_timex_grou_P_NS^.
SCL 90R Depression Score	T1	50.71 (± 8.19)	21	55.19 (± 11.55)	27	P_time^b; P_grou_P_NS; P_timex_grou_P_NS^.
SCL 90 R PSDI	T0	55.90 (± 10.51)	21	61.26 (± 11.40)	27	P_time^b; P_grou_P_NS; P_timex_grou_P_NS
SCL 90 R PSDI	T1	51.71 (± 8.33)	21	52.61 (± 10.66)	27	P_time^b; P_grou_P_NS; P_timex_grou_P_NS

^aP < 0.05.

^bP ≤ 0.001.

Data displays means and standard deviations. BDI: Becks Depression Inventory; BDI-II: Becks Depression Inventory-II; HAMD: Hamilton Depression Rating Scale; IPR: Inventory of personal resources; MaCS: Mannheimer Craving Scale; NS: Not significant; Pgroup: Group effect; Ptime: Effect of time; Ptimexgroup: Interaction effect; SCL: Symptom Checklist.

Citation: Behle N, Kamp F, Proebstl L, Hager L, Riebschläger M, Schacht-Jablonowsky M, Hamdorf W, Neumann S, Krause D, Manz K, Franke AG, Koller G, Soyka M. Treatment outcome, cognitive function, and psychopathology in methamphetamine users compared to other substance users. World J Psychiatry 2022; 12(7): 944-957
URL: https://www.wjgnet.com/2220-3206/full/v12/i7/944.htm
DOI: https://dx.doi.org/10.5498/wjp.v12.i7.944